ELV
Elevance Health, Inc.
Stock
$386.43+4.76 (+1.25%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $276M
- YoY, 2025
- +44.5%
- 5-year CAGR
- −0.5%
- 10-year CAGR
- +6.4%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $276M | +44.5% |
| 2024 | $191M | −33.9% |
| 2023 | $289M | +9.5% |
| 2022 | $264M | +3.5% |
| 2021 | $255M | −9.9% |
| 2020 | $283M | −3.7% |
| 2019 | $294M | +30.1% |
| 2018 | $226M | +32.9% |
| 2017 | $170M | +3.0% |
| 2016 | $165M | +11.3% |
| 2015 | $148M | −12.3% |
| 2014 | $169M | +15.7% |
| 2013 | $146M | −0.3% |
| 2012 | $147M | +8.7% |
| 2011 | $135M | −0.9% |
| 2010 | $136M | −11.5% |
| 2009 | $154M | −1.5% |
| 2008 | $156M | −11.9% |
| 2007 | $177M | — |